Integra Lifesciences Holdings (IART) Total Debt Growth (1y) (2010 - 2026)
Integra Lifesciences Holdings (IART) Total Debt Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 0.12% |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn | -5.76% |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn | 19.06% |
| 10 | Integra Lifesciences Holdings | 1.55 Bn | 1.29 Bn | 216.98 Mn | -35.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.27% |
| Dec 31, 2025 | 6.45% |
| Sep 30, 2025 | -54.54% |
| Jun 30, 2025 | 45.64% |
| Mar 31, 2025 | 34.23% |
| Dec 31, 2024 | 97.73% |
| Sep 30, 2024 | 100.39% |
| Jun 30, 2024 | 3.24% |
| Mar 31, 2024 | 12.21% |
| Dec 31, 2023 | 0.27% |
| Sep 30, 2023 | -7.59% |
| Jun 30, 2023 | -17.45% |
| Mar 31, 2023 | -17.27% |
| Dec 31, 2022 | -10.56% |
| Sep 30, 2022 | 11.75% |
| Jun 30, 2022 | 7.61% |
| Mar 31, 2022 | -3.19% |
| Dec 31, 2021 | -10.43% |
| Sep 30, 2021 | -8.47% |
| Jun 30, 2021 | -14.95% |